SCHEMBL21975463

SCHEMBL21975463

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc(C5(c6ccc7c(c6)sc6ccccc67)c6ccccc6-c6ccccc65)cc4)cc3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
OPRK1 P41145 1/20 0.39
ALDH1A1 P00352 3/20 0.35
HPGD P15428 2/20 0.35
RAB9A P51151 1/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
GPR3 P46089 1/20 0.33
PIM3 Q86V86 1/20 0.32
POLB P06746 2/20 0.32
F9 P00740 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ALOX5 P09917 1/20 0.32
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21975180 1.00 MAPT (0.39) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL21975661 1.00 MAPT (0.39) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL21976046 1.00 MAPT (0.39) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL21976044 0.99 MEN1 (0.40) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL21975542 0.97 MAPT (0.37) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL21975372 0.97 MAPT (0.37) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL21976050 0.96 MAPT (0.36) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL21975181 0.96 MAPT (0.36) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL21975373 0.96 MAPT (0.36) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL21975464 0.96 MAPT (0.36) MAPTMEN1KMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200144511-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DOOSAN CORPORATION (KR) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200144511-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, ORAI2, ORC3 MAPT 1081/4885MEN1 2046/4885KMT2A 1453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.